Yoga-why-upgrade-1674 x 1234.jpg

Hear the difference. Feel the difference.

When you were first implanted, your sound processor helped bring sound back to your world - and changed your life

But what would life be like today if sound was even clearer and hearing became easier? Discover the difference for yourself.

The world is changing at such an amazing rate that if you've had your sound processor for over 6 years, you might be relying on dated technology to help you with your hearing.

Make your life easier, automatically

You go through many different situations during a day - from a quiet room to a windy street or busy playground, from a classroom or an office to a noisy restaurant or family dinner. Imagine hearing more clearly in each of those situations and feeling confident enough about your hearing to do the things that matter most to you. With a next-generation sound processor^, you can go from imagining it to experiencing it.

It all starts with a next-generation sound processor^

"It [Nucleus 7 Sound Processor] just makes me feel included in life."

- Sue, Cochlear™ Nucleus® recipient

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.

In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.

In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement.  Surgery is required to use this product. Any surgical procedure carries risk.

For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.

Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology. Any testimonial featured on this website is intended for an Australian audience only.

For a full list of Cochlear’s trademarks, please visit our Terms of Use page. For a full list of Cochlear's trademarks, please visit our Terms of Use page.For a full list of Cochlear’s trademarks, please visit our Terms of Use page.For a full list of Cochlear’s trademarks, please visit our Terms of Use page.For a full list of Cochlear’s trademarks, please visit our Terms of Use page.For a full list of Cochlear’s trademarks, please visit our Terms of Use page.

^ Cochlear™ Nucleus® Kanso® 2 Sound Processor, Cochlear Nucleus 7 Sound Processor, Cochlear Nucleus Kanso Sound Processor, Cochlear Nucleus 6 Sound Processor.

* Scene Classifier with SCAN technologies. Available in Nucleus 6, Nucleus Kanso, Nucleus 7 and Nucleus Kanso 2 Sound Processors.

# Cochlear True Wirelss™ Devices, Aqua+ accessories, retention accessories. Available for Nucleus 6, Nucleus Kanso, Nucleus 7 and Nucleus Kanso 2 Sound Processors. Please refer to the relevant product information guide for more details on each sound processor and relevant accessory options with their indicated purpose. 

© Cochlear Limited 2023.

  1. Cochlear Ltd (2013) Performance Outcomes of Nucleus® 6 SmartSound® iQ Technology with the First Cochlear Implant Scene Classifier Whitepaper. D464486 ISS3. Data on file.
  2. Mauger SJ, Warren C, Knight M, Goorevich M, Nel E. Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ. International Journey Of Audiology. 2014, Aug; 53(8): 564-576. [Sponsored by Cochlear].
  3. Wolfe J, et al. Benefits of Adaptive Signal Processing in a Commercially Available Cochlear Implant Sound Processor. Otol Neurotol. 2015 Aug; 36(7):1181‐90.
  4. Stefan J. Mauger, Marian Jones, Esti Nel & Janine Del Dot (2017) Clinical outcomes with the Kanso™ off-the-ear cochlear implant sound processor, International Journal of Audiology, 56:4, 267-276, DOI: HYPERLINK “” 10.1080/14992027.2016.1265156
  5. CLTD5606 FDA Study (CIR, D1305388) - Sentence in noise comparing Nucleus SCAN and ForwardFocus (S0N0, S0N3).
  6. Cochlear Ltd. D1376556.CLTD5709 Acceptance and Performance with the Nucleus 7 Cochlear Implant System with Adult Recipients. 2018, Jan. Data on file.
  7. Cochlear Ltd. D1698260. Sound Processor Comparison. 2020, Jul. Data on file.
  8. Duke MM, Wolfe J, Schafer E. Recognition of Speech from the Television with Use of a Wireless Technology Designed for Cochlear Implants. J Am Acad Audiol. 2016;27(5):388-394. doi:10.3766/jaaa.15040
  9. Wolfe J, Morais M, Schafer E. Improving Hearing Performance for Cochlear Implant Recipients with Use of a Digital, Wireless, Remote-Microphone, Audio-Streaming Accessory. J Am Acad Audiol. 2015;26(6):532-539. doi:10.3766/jaaa.15005